Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,686 | 88 | 95.4% |
| Education | $81.00 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.14 | 14 | $0 (2019) |
| Janssen Biotech, Inc. | $186.54 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $177.41 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $132.79 | 7 | $0 (2023) |
| United Therapeutics Corporation | $121.00 | 3 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $111.72 | 7 | $0 (2024) |
| GENZYME CORPORATION | $99.92 | 1 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $95.49 | 3 | $0 (2024) |
| Allergan Inc. | $82.96 | 7 | $0 (2018) |
| Daiichi Sankyo Inc. | $59.05 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $202.73 | 9 | Aurinia Pharma U.S., Inc. ($95.49) |
| 2023 | $130.73 | 7 | GlaxoSmithKline, LLC. ($107.30) |
| 2022 | $63.55 | 3 | GlaxoSmithKline, LLC. ($40.40) |
| 2021 | $67.97 | 4 | Janssen Biotech, Inc. ($36.75) |
| 2020 | $86.35 | 5 | Janssen Biotech, Inc. ($51.67) |
| 2019 | $438.46 | 20 | GENZYME CORPORATION ($99.92) |
| 2018 | $426.48 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($140.09) |
| 2017 | $350.95 | 17 | United Therapeutics Corporation ($121.00) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: GI COLON PREP | ||||||
| 08/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 04/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/31/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Immunology | ||||||
| 01/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $43.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/08/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Gastroenterology | ||||||
| 05/15/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Gastroenterology | ||||||
| 03/22/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Gastroenterology | ||||||
| 07/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Gastroenterology | ||||||
| 02/16/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology | ||||||
| 01/28/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Immunology | ||||||
| 10/12/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Immunology | ||||||
| 06/25/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 646 | 1,057 | $120,327 | $68,450 |
| 2022 | 7 | 661 | 1,069 | $120,695 | $70,026 |
| 2021 | 7 | 658 | 1,061 | $100,079 | $63,262 |
| 2020 | 6 | 696 | 1,090 | $85,970 | $55,173 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 566 | $68,514 | $39,957 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 248 | $20,636 | $11,967 | 58.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $20,888 | $10,057 | 48.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 27 | 32 | $3,232 | $2,322 | 71.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 31 | 61 | $4,047 | $2,284 | 56.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 33 | 43 | $3,010 | $1,864 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 577 | $69,537 | $41,228 | 59.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 109 | 109 | $21,146 | $10,766 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 214 | $17,698 | $10,260 | 58.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 39 | $3,939 | $2,838 | 72.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 35 | 63 | $4,076 | $2,189 | 53.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 33 | 44 | $3,080 | $2,051 | 66.6% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2022 | 12 | 23 | $1,219 | $694.28 | 57.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 262 | 523 | $54,074 | $34,963 | 64.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 175 | 255 | $17,453 | $10,717 | 61.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 74 | 74 | $12,365 | $7,536 | 60.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 47 | 84 | $5,086 | $3,063 | 60.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 32 | 39 | $3,837 | $2,664 | 69.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 47 | 65 | $4,385 | $2,546 | 58.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $2,879 | $1,772 | 61.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 197 | 404 | $35,122 | $22,956 | 65.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 272 | 418 | $24,272 | $14,823 | 61.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 105 | 105 | $14,978 | $10,342 | 69.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 42 | 67 | $3,988 | $2,561 | 64.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 44 | 58 | $3,886 | $2,301 | 59.2% |
About Dr. Mark Mansour, M.D
Dr. Mark Mansour, M.D is a Internal Medicine healthcare provider based in Cameron Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073597241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mansour, M.D has received a total of $1,767 in payments from pharmaceutical and medical device companies, with $202.73 received in 2024. These payments were reported across 90 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,686).
As a Medicare-enrolled provider, Mansour has provided services to 2,661 Medicare beneficiaries, totaling 4,277 services with total Medicare billing of $256,910. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Cameron Park, CA
- Active Since 12/01/2005
- Last Updated 10/12/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073597241
Products in Payments
- BENLYSTA (Biological) $177.41
- STELARA (Biological) $171.87
- STIOLTO RESPIMAT (Drug) $132.80
- ORENITRAM (Drug) $121.00
- XIFAXAN (Drug) $117.62
- RHEUMATOID ARTHRITIS DISEASE (Drug) $99.92
- LUPKYNIS (Drug) $95.49
- Entyvio (Biological) $93.38
- STIOLTO (Drug) $72.95
- INJECTAFER (Drug) $59.05
- XELJANZ (Drug) $43.89
- AVYCAZ (Drug) $38.16
- Actemra (Biological) $38.00
- DALVANCE (Drug) $34.25
- Apligraf (Device) $34.01
- HADLIMA (Drug) $30.51
- OFEV (Drug) $29.39
- DIFICID (Drug) $26.34
- ELEVIEW (Device) $26.22
- SUPREP (Drug) $25.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cameron Park
Dr. Ernest Lo, Md, MD
Internal Medicine — Payments: $15,562
Mamatha Siricilla, M.b.b.s, M.B.B.S
Internal Medicine — Payments: $8,516
Swetha Mudunuri, M.d.,, M.D.,
Internal Medicine — Payments: $1,766
John Kelada, M.d, M.D
Internal Medicine — Payments: $1,486
Dr. Connie Burgeson, Md, MD
Internal Medicine — Payments: $1,071
Dr. Donna Jordan, M.d, M.D
Internal Medicine — Payments: $148.44